Does Automated Versus Manual Ki67 Labeling Index Assessment Influence Risk Stratification in Patients with Localized Adrenocortical Carcinoma? Lessons from the ADIUVO Trial. [PDF]
Vermeulen MA +14 more
europepmc +1 more source
Adrenocortical Carcinoma: An Exceptional Survival Span Across a Tailored Management. [PDF]
Carsote M +8 more
europepmc +1 more source
Real-world safety profile of mitotane in adrenocortical carcinoma: a retrospective cross-sectional study integrating pharmacovigilance and interpretable machine learning. [PDF]
Wang J, Yang Y, Xu K, Hou N, Guo C.
europepmc +1 more source
Systemic management of adrenal malignancies: adrenocortical carcinoma and pheochromocytoma/paraganglioma. [PDF]
Hernandez-Felix JH +5 more
europepmc +1 more source
Concomitant parathyroid hormone-secreting oncocytic adrenocortical carcinoma and parathyroid adenoma. [PDF]
Moreno NA +5 more
europepmc +1 more source
Direct thyroid toxicity and sex differences in mitotane-induced hypothyroidism and dyslipidemia in thyroidology. [PDF]
Sengul I, Sengul D.
europepmc +1 more source
Adrenocortical carcinoma (ACC) is a rare and aggressive neoplasm, often associated with poor prognosis, due to the limited therapeutic options currently available.
Società Italiana di Biologia Sperimentale
doaj
Hope is everything - an hermeneutic phenomenological study on the lived experiences of individuals with adrenocortical carcinoma. [PDF]
Yeoh P, Sturt J, Czuber-Dochan W.
europepmc +1 more source
Sarcomatoid adrenocortical carcinoma with aggressive disease course: a rare case report and literature review. [PDF]
Xu XX +9 more
europepmc +1 more source
Gemcitabine and oxaliplatin combination in patients with advanced adrenocortical carcinoma. [PDF]
Chen L +7 more
europepmc +1 more source

